SCHEMBL30190097

SCHEMBL30190097

C[C@@H](CO)c1c(O)c(O)c2c(c1O)C(=O)C(O)=C1C(C)(C)CCC[C@@]12C

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.37
▸ EPAS1 Q99814 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30190196 0.71 EP300 (0.35) —
SCHEMBL22861879 0.71 EP300 (0.35) —
SCHEMBL31571680 0.64 CACNA1G (0.31) HIF1AEPAS1
Taiwaniaquinol D SCHEMBL31237203 0.59 AKR1B1 (0.35) —
Taiwaniaquinol D SCHEMBL18105235 0.59 AKR1B1 (0.35) —
SCHEMBL3186292 0.59 SOD1 (0.43) HIF1AEPAS1
SCHEMBL22862032 0.57 EP300 (0.40) —
SCHEMBL22861906 0.57 EP300 (0.40) —
SCHEMBL21291523 0.57 EP300 (0.40) —
SCHEMBL21291508 0.57 EP300 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4401711-A1 STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 — — EP disclosed
EP-4401714-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 — — EP disclosed
EP-4401712-A1 ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2024-07-24 — — EP disclosed
EP-4401713-A1 ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS Nulixir Inc. (US) 2024-07-24 — — EP disclosed
US-20240165036-A1 ENCAPSULATED VITAMIN D Nulixir Inc. 2024-05-23 — — US disclosed
US-20230404126-A1 ENCAPSULATED PRECURSORS OF NICOTINAMIDE ADENINE DINUCLEOTIDE AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-12-21 — — US disclosed
US-20230157963-A1 SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-05-25 — — US disclosed
US-20230157973-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-05-25 — — US disclosed
US-20230149829-A1 ORAL COMPOSITIONS OF PLANTS THROUGH A DOUBLE EXTRACTION SYSTEM AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-05-18 — — US disclosed
US-20230111238-A1 STABLE COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-04-13 — — US disclosed
US-20230111190-A1 ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-04-13 — — US disclosed
US-20230111756-A1 STABLE FORMULATIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-04-13 — — US disclosed
US-20230110485-A1 MULTI-LAYER PARTICLES OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-04-13 — — US disclosed
WO-2023043853-A1 ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2023-03-23 — — WO disclosed
WO-2023043855-A1 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2023-03-23 — — WO disclosed
WO-2023043852-A1 STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. (US) 2023-03-23 — — WO disclosed
WO-2023043854-A1 ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS Nulixir Inc. (US) 2023-03-23 — — WO disclosed
US-20230079480-A1 STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-03-16 — — US disclosed
US-20230082651-A1 STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-03-16 — — US disclosed
US-20230081296-A1 STABLE NON-AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME Nulixir Inc. 2023-03-16 — — US disclosed
Send feedback